Beyond shy: When to suspect social anxiety disorder

Journal of Family Practice

Volumn 56, Issue 5, 2007, Pages 369-374

  Rosenthal, Jessica ^a   Jacobs, Leslie ^a   Marcus, Madalyn ^a   Katzman, Martin A ^b,c  

^a START Clinic for Mood and Anxiety Disorders   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c START Clinic for Mood and Anxiety Disorders   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; DIFFERENTIAL DIAGNOSIS; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; SOCIAL BEHAVIOR; SOCIAL PHOBIA;

EID: 34249033390     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Connor KM, Kobak KA, Churchill LE, Katzelnick D, Davidson JR. Mini-Spin: A brief screening assessment for generalized social anxiety disorder. Depress Anxiety 2001; 14:137-140.
2. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12 month prevalence of DSM III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51:8-19.
3. Robins LN, Regier DA. Psychiatric Disorders in America: The Epidemiological Catchment Area Study. New York: Free Press; 1990.
4. Eaton WW, Weissman M. Panic and phobias. In: Robins E, DA Regier, eds. Psychiatric Disorders in America: The Epidemiological Catchment Area Study. New York: Free Press; 1991:155-179.
5. Scheier FR, Johnson J, Hornig, CD, Liebowitz, MR, Weissman MM. Social phobia: Comorbidity and morbidity in an epidemiological sample. Arch Gen Psychiatry 1992; 49:282-288.
6. Kessler RC, Chiu WT, Demier O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005; 62:617-627.
7. Lepine JP, Pelissolo A. Why take social anxiety disorder seriously? Depress Anxiety 2000; 11:87-92.
8. Wittchen HU, Fuetsch M, Sonntag H, Muller N, Liebowitz M. Disability and quality of life in pure and comorbid social phobia - findings from a controlled study. Eur Psychiatry 1999; 14:118-131.
9. Stein MB, Chavira DA. Subtypes of social phobia and comorbidity with depression and other anxiety disorders. J Affect Disord 1998; 50:S11-S16.
10. Valente S. Social phobia. J Am Psychiatric Nurses Assoc 2002; 8:67-75.
11. Beidel DC. Social phobia: etiology and evolution. J Clin Psychiatry 1998; 59(Suppl 17):27-31.
12. Greist JH. The diagnosis of social phobia. Clin Psychiatry 1995; 56(5):5-12.
13. Den Boer JA, Baldwin D, Bobes J, Katschnig H, Westenberg H, Wittchen HU. Social anxiety disorder - our current understanding. Intl J Psychiatry Clin Pract 1999; 3:S3-S12.
14. Montgomery SA. Social phobia: Diagnosis, severity and implications for treatment. Eur Arch Psychiatry Clin Neurosci 1999; 249:S1-S6.
15. Davidson JR, Potts NL, Richichi E, et al. Treatment of social phobia with Clonazepan and placebo. J Clin Pharmacol 1993; 13:423-428.
16. Kasper S. Social phobia: The nature of the disorder. J Affect Disord 1998; 50:S3-S9.
17. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, 4th ed, text rev. Washington, DC: APA; 2000.
18. Ross J. Social phobia: The consumer's perspective. J Clin Psychiatry 1993; 54:S5-S9.
19. Bruce TJ, Saeed SA. Social anxiety disorder: A common under recognized mental disorder. Am Fam Physician 1999; 60:2311-2322.
20. Connor K T, Davidson JRT, Churchill E, Sherwood A, Foa E, Weisler RH. Psychometric properties of the Social Phobia Inventory (SPIN). Br J Psychiatry 2000; 176:379-386.
21. Watson D, Friend R. Measurement of social-evaluative anxiety. J Consulting Clin Psychol 1969; 33:448-457.
22. Heimberg RG, Hope DA, Rapee RM, Bruch MA. The validity of the Social Avoidance and Distress Scale and the Fear of Negative Evaluation Scale with social phobic patients. Behav Res Ther 1988; 26:407-410.
23. Antony M, Swinson R. The Shyness and Social Anxiety Workbook: Proven Techniques for Overcoming Your Fears. Oakland, Calif: New Harbinger; 2000.
24. Safren SA, Heimberg R, Brown E, Holle C. Quality of life in social phobia. Depress Anxiety 1996/1997; 4:126-133.
25. Heimberg RG, Liebowitz, MR, Hope DA, et al. Cognitive behavioral group therapy vs phenelzine therapy for social phobia. Arch Gen Psychiatry 1998; 55:1133-1141.
26. Van V, Den Boer JA, Westenberg HG. Psychopharmacological treatment of social phobia: A double blind placebo controlled study with Fluvoxamine. Psychopharmacol 1994; 115:128-134.
27. Kelsey JE. Venlafaxine in social phobia. Psychopharmacol Bull 1995; 31:767-771.
28. Allgulander C. Paroxetine in social anxiety disorder: A randomized placebo controlled study. Acta Psychiatr Scand 1999; 100:193-198.
29. Muller JE, Koen L, Seedat S, Stein DJ. Social anxiety disorder: current treatment recommendations. CNS Drugs 2005; 19:377-391.
30. Sareen L, Stein M. A review of the epidemiology and approaches to the treatment of social anxiety disorder. Drugs 2000; 3:497-509.
31. Lader M. The clinical relevance of treating social phobia. J Affect Disord 1998; 50:S29-S34.
32. Dupont RL, Rice DP, Miller LS, Shiraki SS, Rowland CR, Harwood HJ. Economic costs of anxiety disorders. Anxiety 1996; 2:167-172.
33. Wittchen HU, Fuetsch M, Sonntag H, Muller N, Liebowitz M. Disability and quality of life in pure and comorbid social phobia: findings from a controlled study. Eur Psychiatry 1999; 14:118-131.